TLSA
Tiziana Life Sciences Ltd.
NASDAQ · Healthcare · Biotechnology · GB
$1.01
−3.81%Leverage
- Debt / equity
- -0.34x
- Net debt / equity
- 0.82x
- Debt / assets
- 0.08x
- Debt / EBITDA
- -0.04x
- Net debt / EBITDA
- 0.10x
Liquidity & coverage
- Current ratio
- 0.69x
- Quick ratio
- 0.69x
- Cash ratio
- 0.23x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- -$4.1M
Cash & dividend
- FCF / debt
- -14.44x
- Cash flow / debt
- -14.36x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026